Company Filing History:
Years Active: 2014
Title: The Innovative Contributions of Anna A. Sablina
Introduction
Anna A. Sablina is a prominent inventor based in Kessel-lo, Belgium. She has made significant strides in the field of biotechnology, particularly in the development of antibodies that target specific phosphorylated proteins. Her work has implications for diagnostic methods and therapeutic applications.
Latest Patents
Anna A. Sablina holds a patent for "Phosphorylated RaIA." This patent describes antibodies that are specific for human Ra1A, which is phosphorylated at one or both of Ser183 and Ser194. The patent outlines various methods for utilizing these antibodies, including diagnostic and screening methods.
Career Highlights
Anna is affiliated with the Dana-Farber Cancer Institute Inc., where she contributes to groundbreaking research in cancer biology. Her expertise in antibody development has positioned her as a key figure in her field.
Collaborations
Throughout her career, Anna has collaborated with notable colleagues, including William C. Hahn and Laura Corral. These partnerships have enhanced her research and expanded the impact of her innovations.
Conclusion
Anna A. Sablina's contributions to biotechnology, particularly through her patented work on phosphorylated antibodies, highlight her role as an influential inventor in the scientific community. Her ongoing research continues to pave the way for advancements in cancer diagnostics and treatment.